RS50758B - Postupak za dobijanje proizvoda tipa tiazolo (3,4,5-de) (4,1) benzotiazepina - Google Patents
Postupak za dobijanje proizvoda tipa tiazolo (3,4,5-de) (4,1) benzotiazepinaInfo
- Publication number
- RS50758B RS50758B RSP-2009/0238A RSP20090238A RS50758B RS 50758 B RS50758 B RS 50758B RS P20090238 A RSP20090238 A RS P20090238A RS 50758 B RS50758 B RS 50758B
- Authority
- RS
- Serbia
- Prior art keywords
- trifluoromethyl
- benzothiazepine
- dihydro
- thiazolo
- imino
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/06—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/26—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
- C07C271/28—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a non-condensed six-membered aromatic ring
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurosurgery (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Psychology (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Postupak za dobijanje metansulfonata 6,6-dioksida 2-imino-9-trifluorometil-4,5-dihidro-2H,7H-tiazolo[3,4,5-de][4,l]benzotiazepina karakterističan po tome što:a) 4-trifluorometilanilin I se zaštiti u prisustvu di-terc-butil dikarbonata u monohlorobenzenu na refluksu zatim,b) 4-trifluorometil fenilkarbamat terc-butila izolovan u prethodnoj etapi se transformiše u 2-hidroksimetil-4-trifluorometil fenilkarbamat bez izolovanja intermedijera 2-formil-4-trifluorometil fenilkarbamata zatim,c) 2-hidroksimetil-4-trifluorometil fenilkarbamat izolovan u prethodnoj etapi se transformiše direktno u 7 -trifluorometil-1,5-dihidro-3H-[4,l]benzotiazepin-2-on u prisustvu kiseline tioglikolne ijedne katalitičke količine kiseline p-toluen sulfonske zatim,d) 7-trifluorometil-l,5-dihidro-3H-[4,l]benzotiazepin-2-on izolovan u prethodnoj etapi se redukuje kako bi se dobio 7 -trifluorometil-1,2,3,5-tetrahidro-[4,l]benzotiazepin zatim,e) 7 -trifluorometil-l,2,3,5-tetrahidro-[4,l]benzotiazepin izolovan u prethodnoj etapi se transformiše u bromhidrat 2-imino-9-trifluorometil-4,5-dihidro-2H,7H-tiazolo[3,4,5-de][4,l]benzotiazepina u prisustvu broma, kalijum tiocijanata u sirćetnoj kiselini zatim,f) bromhidrat 2-imino-9-trifluorometil-4,5-dihidro-2H,7H-tiazolo[3,4,5-de][4, ljbenzotiazepina se oksidiše u 6,6-dioksid 2-imino-9-trifluorometil-4,5-dihidro-2H,7H-tiazolo[3,4,5-de][4,l]benzotiazepina zatim se transformiše u prisustvu kiseline metan sulfonske u metansulfonat 6,6-dioksida 2-imino-9-trifluorometil-4,5-dihidro-2H.7H-tiazolo[3,4,5-de] [4,1 jbenzo-tiazepina.Prijava sadrži još 14 zavisnih patentnih zahteva.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0314574A FR2863612B1 (fr) | 2003-12-12 | 2003-12-12 | PROCEDE DE FABRICATION DE PRODUIT DE TYPE THIAZOLO[3,4,5-de] [4,1]BENZOTHIAZEPINE |
PCT/FR2004/003138 WO2005066146A1 (fr) | 2003-12-12 | 2004-12-07 | Procede de fabrication de produit de type thiazolo[3,4,5-de][4,1]benzothiazepine |
Publications (1)
Publication Number | Publication Date |
---|---|
RS50758B true RS50758B (sr) | 2010-08-31 |
Family
ID=34610602
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RSP-2009/0238A RS50758B (sr) | 2003-12-12 | 2004-12-07 | Postupak za dobijanje proizvoda tipa tiazolo (3,4,5-de) (4,1) benzotiazepina |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP1694658B1 (sr) |
JP (1) | JP2007519621A (sr) |
AR (1) | AR046872A1 (sr) |
AT (1) | ATE423773T1 (sr) |
CY (1) | CY1109046T1 (sr) |
DE (1) | DE602004019678D1 (sr) |
DK (1) | DK1694658T3 (sr) |
ES (1) | ES2322857T3 (sr) |
FR (1) | FR2863612B1 (sr) |
HR (1) | HRP20090237T1 (sr) |
PL (1) | PL1694658T3 (sr) |
PT (1) | PT1694658E (sr) |
RS (1) | RS50758B (sr) |
SI (1) | SI1694658T1 (sr) |
TW (1) | TW200530256A (sr) |
UY (1) | UY28665A1 (sr) |
WO (1) | WO2005066146A1 (sr) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3810450B2 (ja) * | 1993-09-24 | 2006-08-16 | 武田薬品工業株式会社 | 縮合環化合物とその用途 |
JPH08259447A (ja) * | 1995-03-24 | 1996-10-08 | Takeda Chem Ind Ltd | コレシストキニン拮抗剤 |
FR2766487B1 (fr) * | 1997-07-28 | 1999-08-27 | Rhone Poulenc Rorer Sa | Thiazolobenzoheterocycles, leur preparation et les medicaments les contenant |
-
2003
- 2003-12-12 FR FR0314574A patent/FR2863612B1/fr not_active Expired - Fee Related
-
2004
- 2004-12-06 AR ARP040104548A patent/AR046872A1/es not_active Application Discontinuation
- 2004-12-07 PT PT04805651T patent/PT1694658E/pt unknown
- 2004-12-07 DK DK04805651T patent/DK1694658T3/da active
- 2004-12-07 AT AT04805651T patent/ATE423773T1/de active
- 2004-12-07 SI SI200431113T patent/SI1694658T1/sl unknown
- 2004-12-07 JP JP2006543580A patent/JP2007519621A/ja not_active Ceased
- 2004-12-07 EP EP04805651A patent/EP1694658B1/fr active Active
- 2004-12-07 PL PL04805651T patent/PL1694658T3/pl unknown
- 2004-12-07 DE DE602004019678T patent/DE602004019678D1/de active Active
- 2004-12-07 WO PCT/FR2004/003138 patent/WO2005066146A1/fr active Application Filing
- 2004-12-07 ES ES04805651T patent/ES2322857T3/es active Active
- 2004-12-07 RS RSP-2009/0238A patent/RS50758B/sr unknown
- 2004-12-10 TW TW093138223A patent/TW200530256A/zh unknown
- 2004-12-10 UY UY28665A patent/UY28665A1/es unknown
-
2009
- 2009-04-22 HR HR20090237T patent/HRP20090237T1/xx unknown
- 2009-05-11 CY CY20091100500T patent/CY1109046T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
TW200530256A (en) | 2005-09-16 |
AR046872A1 (es) | 2005-12-28 |
SI1694658T1 (sl) | 2009-08-31 |
HRP20090237T1 (en) | 2009-06-30 |
WO2005066146A1 (fr) | 2005-07-21 |
CY1109046T1 (el) | 2014-07-02 |
EP1694658A1 (fr) | 2006-08-30 |
DE602004019678D1 (de) | 2009-04-09 |
UY28665A1 (es) | 2005-07-29 |
ATE423773T1 (de) | 2009-03-15 |
JP2007519621A (ja) | 2007-07-19 |
DK1694658T3 (da) | 2009-06-15 |
EP1694658B1 (fr) | 2009-02-25 |
PT1694658E (pt) | 2009-04-23 |
PL1694658T3 (pl) | 2009-07-31 |
ES2322857T3 (es) | 2009-06-30 |
FR2863612A1 (fr) | 2005-06-17 |
FR2863612B1 (fr) | 2006-03-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TNSN02012A1 (fr) | Derives de pyrimidine nouveaux inhibiteurs de mmp, et compositions les contenant | |
ES2194209T3 (es) | Inhibidores de metaloproteasa de tiol sulfona. | |
WO2003086294A3 (en) | 1h-benzo[f]indazol-5-yl derivatives as selective glucocorticoid receptor modulators | |
MA27313A1 (fr) | Pates veterinaires homogenes orales anthelminthiques. | |
EP1170288A3 (fr) | Dérivés de diphenylurée et leur utilisation en tant qu'antagonistes alpha2/5-HT2c | |
JP2011063599A (ja) | ヘテロ環式フルオロアルケニルスルホンの製造方法 | |
KR101198582B1 (ko) | 스테아로일-coa 불포화화 효소의 억제제 | |
DE60014369D1 (de) | Propansäurederivate, die die bindung von integrinen an ihre rezeptoren behindern | |
CA2048325A1 (en) | Acetamide derivatives | |
DE502004002037D1 (de) | Umgelagerte pentanole, ein verfahren zu ihrer herstellung und ihre verwendung als entz ndungshemmer | |
RS50758B (sr) | Postupak za dobijanje proizvoda tipa tiazolo (3,4,5-de) (4,1) benzotiazepina | |
Porter et al. | Potent and selective inhibitors of gelatinase-A 1. Hydroxamic acid derivatives | |
DE69821347D1 (de) | (2-(2-thienyl)-ethylamino)-(2-halophenyl)-acetonitrile als zwischenprodukte und verfahren zu ihrer herstellung | |
AU9446298A (en) | Novel 3,4-diarylthiazolin-2-one or -2-thione derivatives, preparation methods and uses in therapy | |
DE60037337D1 (de) | Herstellung einer wolfram-gateelektrode | |
US4242518A (en) | Thiophene compounds and their manufacture | |
Yale et al. | Novel polycyclic heterocycles. Derivatives of 5, 11-dihydrodibenz [b, e][1, 4] oxazepine and 5, 11-dihydrodibenzo [b, e][1, 4] thiazepine | |
HUP0104190A2 (hu) | Eljárás 2-alkil-3-(4,5-dihidroizoxazol-3-il)-halogén-benzol szulfid-, szulfoxid- és szulfon-származékainak előállítására | |
DE3889497T2 (de) | 3,4-Dihydro-2-alkyl-3-oxo-N-aryl-2H-[1]benzothieno[3,2-e]-1,2-thiazine-4-carboxamid-1,1-dioxide. | |
NO774035L (no) | Nye 2-sulfonyl (resp. -sulfinyl)-2`-aminoacetofenoner og fremgangsmaate til deres fremstilling | |
KR100199067B1 (ko) | 설피닐프 리스 티나마이신 iib의 제조방법 | |
WO1999036476A3 (en) | Improved method of making sulfanatophenyl substituted porphines | |
HU192973B (en) | New process for reducing sulfochlorides, sulfoxides and alpha-halogenocarbonyl compounds for producing dithio-, thio- or carbonyl compounds | |
DE60218761D1 (de) | Stabilisierte wässrige folsäurezubereitung und verfahren zu dessen herstellung | |
Yeung et al. | A synthesis of 4-thiomethylbenzisothiazolone-1, 1-dioxide using HDPT |